GTN Company

GTN innovates a quantum machine learning technology to transform drug discovery.


Connections from

Technology: Small Molecules
Industry: AI in Pharma, Early Drug Development
Headquarters: London, England, United Kingdom
Founded Date: 2017-05-17
Employees Number: 1-10
Funding Status: Seed
Investors Number: 6
Total Funding: 2100000
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-11-01
Last Funding Type: Seed

Visit Website
Register and Claim Ownership